MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 7.24
-0.01 (-0.14%)
May 14, 2026, 5:25 PM CET
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €136.62 million as of May 14, 2026. Its market cap has increased by 51.67% in one year.
Market Cap
136.62M
Enterprise Value
129.19M
Revenue
4.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
€7.24
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has increased from 132.73M to 136.62M, an increase of 2.93%. That is a compound annual growth rate of 0.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 136.62M | 76.36% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | 132.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genfit | 441.19M |
| Cellectis | 245.21M |
| Sensorion | 213.87M |
| Transgene | 212.53M |
| ABIONYX Pharma | 128.41M |
| Innate Pharma | 118.41M |
| OSE Immunotherapeutics | 99.28M |
| Adocia | 96.60M |